Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …

S Singh, YK Loke, CD Furberg - Jama, 2008 - jamanetwork.com
Context Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely
used in patients with chronic obstructive pulmonary disease (COPD) but their effect on the …
被引用次数：645 相关文章

[引用][C] Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …

S Singh, YK Loke, CD Furberg - JAMA: The Journal of …, 2008 - research-portal.uea.ac.uk
Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with
chronic obstructive pulmonary disease: a systematic review and meta-analysis — University of …

[引用][C] Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease

S Singh - JAMA, 2008 - cir.nii.ac.jp
Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With
Chronic Obstructive Pulmonary Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF] academia.edu

[PDF][PDF] Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease

S Singh, YK Loke, CD Furberg - JAMA, 2008 - academia.edu
Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With
Chronic Obstructive Pulmonary Disease Page 1 Vol. 300 No. 12, September 24, 2008 JAMA • …

[引用][C] Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and …

S SINGH, YK LOKE… - JAMA, the journal of the …, 2008 - pascal-francis.inist.fr
Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With
Chronic Obstructive Pulmonary Disease : A Systematic Review and Meta-analysis CNRS Inist …
[PDF] psu.edu

[PDF][PDF] Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease

S Singh, YK Loke, CD Furberg - JAMA, 2008 - Citeseer
HP Smart Web Printing Page 1 Vol. 300 No. 12, September 24, 2008 JAMA • Online
Features Review CLINICIAN'S CORNER Inhaled Anticholinergics and Risk of Major …
[HTML] nih.gov

[HTML][HTML] Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …

S Singh, YK Loke, CD Furberg - … of Abstracts of Reviews of Effects …, 2008 - ncbi.nlm.nih.gov
This review found that inhaled anticholinergics are associated with a significantly increased
risk of cardiovascular death, myocardial infarction or stroke among patients with chronic …

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …

S Singh, YK Loke, CD Furberg - JAMA, 2008 - pubmed.ncbi.nlm.nih.gov
Context Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely
used in patients with chronic obstructive pulmonary disease (COPD) but their effect on the …
[PDF] researchgate.net

[PDF][PDF] Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease

JAMA, 2008 - researchgate.net
Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With
Chronic Obstructive Pulmonary Disease Page 1 CLINICIAN’S CORNER REVIEW Inhaled …

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta …

S Singh, YK Loke, CD Furberg - JAMA, 2008 - europepmc.org
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic
obstructive pulmonary disease: a systematic review and meta-analysis. - Abstract - Europe …